Image-guided therapy
IntraSight interventional platform
Best-in-class interventional tools built for today’s lab, ready for tomorrow’s innovations
Introducing Philips IntraSight interventional applications platform where imaging, physiology, co-registration* and software come together to facilitate optimal patient care. IntraSight offers a comprehensive suite of clinically proven modalities, such as, iFR/FFR, IVUS and co-registration* to simplify complex interventions, speed routine procedures and provide improved patient care.
Advanced protection against cybersecurity threats
With the most robust cybersecurity, which runs on Microsoft Windows 10, providing you with the latest data encryption and protection against cybersecurity threats.
Built on a smart, applications-based platform
IntraSight can scale to meet the evolving needs of your lab when new applications or modalities become available, without the need to purchase new hardware. Only Philips Interventional Applications Platform, IntraSight, offers best-in-class imaging and physiology tools with iFR, iFR Co-registration*, FFR, IVUS, IVUS Co-registration*, and Angio+*. With its modular architecture, IntraSight stays on top of latest advances and important security updates.
Minimize learning curves and increase workflow confidence
- Navigate and measure faster with an intuitive user interface and enhanced measurement tools
- Facilitate faster training without using a catheter or wire in the all new demonstration mode
- Save time and reduce frustration with faster workflows and faster transitions between iFR, IVUS and co-registration6
- Utilize new snapshot and reporting features
Easy-to-use, small footprint, digital IVUS imaging and physiology system
IntraSight Mobile is designed for peripheral vascular and coronary procedures, operable directly from the sterile field. This is available for the hospital, office-based lab, and ambulatory surgery center environment.
Footnotes
- Co-registration tools available within IntraSight 7 configuration via SyncVision.
- Lawton J. et al. 2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization. JACC. 2022;79(2):e21-e129.
- 2018 ESC/EACTS Guidelines on myocardial revascularization: The task force on myocardial revascularization of the European society of cardiology (ESC) and European association for cardio-thoracic surgery (EACTS). Eur Heart J. 2018;00:1-96.
- Co-registration tools available within IntraSight 7 configuration via SyncVision.
- *Philips Mobile Interventional Applications Platform – IntraSight Mobile – is CE marked for sale in Europe and has received FDA 510(k) clearance for sale in the U.S.
Disclaimer
Always read the label and follow the directions for use.
Philips medical devices should only be used by physicians and teams trained in interventional techniques, including training in the use of this device.
Products subject to country availability. Please contact your local sales representative.
©2025 Koniklijke Philips N.V. All rights reserved. Trademarks are the property of Koninklijke Philips N.V. or their respective owners. Philips reserves the right to change product specifications without prior notification.